Teyi Pharmaceutical: Dongguan Securities\'s inspection opinions on Teyi Pharmaceutical\'s use of simple procedures to issue shares to specific targets in 2023 to temporarily supplement working capital

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.